எலும்பு நோய் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from எலும்பு நோய். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In எலும்பு நோய் Today - Breaking & Trending Today

Study reveals major factors that affect bone health in hematopoietic stem cell transplantation recipients


Study reveals major factors that affect bone health in hematopoietic stem cell transplantation recipients
Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant hematological diseases.
To address this serious problem, the International Osteoporosis Foundation (IOF) expert Working Group on Cancer and Bone Disease has published a new Executive Summary of its authoritative state-of-the-art review.
The review outlined the major factors affecting bone health in HSCT patients, and provided expert guidance for the monitoring, evaluation and treatment of bone loss in these patients. Published in the ....

Nicholas Harvey , Emily Henderson , Bone Working Group , University Of Southampton , International Osteoporosis Foundation , Group On Cancer , Committee Of Scientific Advisors , University Hospitals Of Geneva , Working Group , Bone Disease , Executive Summary , Bone Oncology , Emeritus Professor , University Hospitals , Scientific Advisors , International Osteoporosis , Clinical Epidemiology , Epidemiology Unit , One Health , நிக்கோலஸ் ஹார்வி , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் ஆஃப் சவுத்தாம்ப்டன் , சர்வதேச அஸ்டீயாப்ரோஸிஸ் அடித்தளம் , பல்கலைக்கழகம் மருத்துவமனைகள் ஆஃப் ஜிநீவ , வேலை குழு , எலும்பு நோய் ,

How to manage osteoporosis in hematologic stem cell transplant recipients


 E-Mail
Impaired bone health is among the most significant long-term consequences of hematopoietic stem cell transplantation (HSCT), a common therapy for patients with malignant and non-malignant haematological diseases.
To address this serious problem, the International Osteoporosis Foundation (IOF) expert Working Group on Cancer and Bone Disease has published a new Executive Summary of its authoritative state-of-the-art review. The review outlined the major factors affecting bone health in HSCT patients, and provided expert guidance for the monitoring, evaluation and treatment of bone loss in these patients. Published in the
Journal of Bone Oncology, the Executive Summary now provides a helpful management algorithm and succinct key guidance based on the Working Group s expert opinion. ....

United Kingdom , Nicholas Harvey , Bone Working Group , University Of Southampton , International Osteoporosis Foundation , Group On Cancer , Committee Of Scientific Advisors , University Hospitals Of Geneva , Working Group , Bone Disease , Executive Summary , Bone Oncology , Emeritus Professor , University Hospitals , Scientific Advisors , Clinical Epidemiology , Epidemiology Unit , Medicine Health , Internal Medicine , Metabolism Metabolic Diseases , Orthopedic Medicine , Rehabilitation Prosthetics Plastic Surgery , ஒன்றுபட்டது கிஂக்டம் , நிக்கோலஸ் ஹார்வி , பல்கலைக்கழகம் ஆஃப் சவுத்தாம்ப்டன் , சர்வதேச அஸ்டீயாப்ரோஸிஸ் அடித்தளம் ,

Multiple Sclerosis treatment breakthrough


(Pixabay)
Thanks to COVID and virus research, a new mRNA ‘Vaccine Treatment’ for MS is in final development. The Multiple Sclerosis Society of Canada made the announcement in their January 25, 2021 Newsletter. They wrote:
“BioNTech is Applying mRNA Vaccine Technology to Treat Multiple Sclerosis. BioNTech, a German biotechnology company that is working with Pfizer to develop a COVID-19 vaccine, reports that they are using the same technology to develop a therapeutic approach to multiple sclerosis (MS).” Jan. 25, 2021
Yahoo Finance Reports on BioNTech; “With the MS vaccine, the mRNA technology stops the body s immune system from attacking neurons in the brain and spinal cord.” ....

Derrick Rossi , Sclerosis Society Of Canada , Rna Vaccine Technology To Treat Multiple Sclerosis , Biontech Biotechnology Company , Virus Research , Vaccine Treatment , Multiple Sclerosis Society , Treat Multiple , Finance Reports , Personal Contact , Medical Profession , Virus Theory , Bone Disease , Biotechnology Company , Canadian Derrick Rossi , டெரிக் ரோஸி , ஸ்க்லரோசிஸ் சமூகம் ஆஃப் கனடா , வைரஸ் ஆராய்ச்சி , தடுப்பூசி சிகிச்சை , பல ஸ்க்லரோசிஸ் சமூகம் , உபசரிப்பு பல , நிதி அறிக்கைகள் , தனிப்பட்ட தொடர்பு , மருத்துவ ப்ரொஃபெஶந் , வைரஸ் கோட்பாடு , எலும்பு நோய் ,